Technology
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines – News-Medical.Net
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines…
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The lipid nanoparticle (LNP) delivery vehicles have inherent immunostimulatory properties that can induce adverse events such as allergic reactions.
Now, Ronald Levy and colleagues from Stanford University…
-
Noosa News24 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News17 hours agoDistress call sparks rescue operation for capsized sailor near North Stradbroke Island
-
Business17 hours agoBell Potter names more of the best ASX 200 stocks to buy in April
-
Noosa News24 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots